Niehs: this acquisition will provide 60 vials of spheroid-qualified human liver cells from 30 male and 30 female donors to support ncats/niehs complement-arie research focused on developing 3D…
Active Purchase Order Awarded Last action
- Contract number
- 75N98026P01800
- Awardee
-
Lonza Walkersville, Inc. UEI LEEXJC9L4NF5
- Awarding agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Obligated
- $30,645
Award facts
- Opportunity
-
- Lonza – Cryopreserved Primary Human Hepatocytes (spheroid-qualified) Solicitation · 75N98026Q01231 · Posted Sep 16, 2026
- Contract value 100% obligated
- $30,645.00 Current and potential, with all options
- Completion date 7% complete
- Current and potential, with all options
- Funding agency
- National Institute of Environmental Health Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27709, USA
Award details come from SAM.gov/FPDS.
About this award
The National Institute of Environmental Health Sciences issued a purchase order to Lonza Walkersville, Inc. on September 29, 2026, for sixty vials of spheroid-qualified cryopreserved primary human hepatocytes, valued at $30,645.00, with firm-fixed-price pricing.
The procurement supplies thirty male and thirty female donor cell preparations to support Complement-ARIE research conducted jointly by the National Center for Advancing Translational Sciences and NIEHS Mechanistic Toxicology Branch. The cells are qualified for three-dimensional spheroid formation and will model chemically induced liver injury and fibrotic progression in microphysiological systems. Place of performance is Durham, North Carolina. Delivery was required by September 25, 2026, with ultimate completion scheduled for September 28, 2027. The order was issued under simplified acquisition procedures as a commercial item; extensive market research identified Lonza as the sole source capable of providing spheroid-qualified cryopreserved primary human hepatocytes with matched male and female donor lots appropriately re-qualified for the government's established applications.
Description
Niehs: this acquisition will provide 60 vials of spheroid-qualified human liver cells from 30 male and 30 female donors to support ncats/niehs complement-arie research focused on developing 3D microphysiological systems for modeling chemically induce
Quick answers
Who was awarded contract 75N98026P01800?
75N98026P01800 was awarded to Lonza Walkersville, Inc. by Office of Logisitics and Acquisition Operations (National Institutes of Health) on September 29, 2026.
How much is contract 75N98026P01800 worth?
The government has obligated $30,645 on 75N98026P01800.
Which agency awarded contract 75N98026P01800?
Office of Logisitics and Acquisition Operations (National Institutes of Health) awarded 75N98026P01800, with funding from National Institute of Environmental Health Sciences (National Institutes of Health).
Was contract 75N98026P01800 competed?
The extent of competition for 75N98026P01800 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award